Everest Organics Ltd Stock Analysis

Small Cap
Evaluated by 135 users | BSE: 524790 | NSE: |
Pharmaceuticals & Drugs

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
Return on Capital Employed 12.31%13.86%10.99%9.77%13.29%8.03%9.26%9.39%22.13%26.14%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 53.761.179.69610699.5107112156167
Y-o-Y Gr. Rt.-13.6%30.5%20.6%10.4%-6.1%7.5%4.9%38.9%7.3%
Adjusted EPS (Rs.)
Y-o-Y Gr. Rt.-4.9%-41.1%13.2%164%-4.4%-32.3%32%383%42.6%
Book Value per Share (Rs.) 1.612.763.554.486.2617.9420.1323.3532.4742.75
Adjusted Net Profit
Net Op. Cash Flow (Rs. Cr.)
Debt to Cash Flow from Ops 2.853.222.723.695.923.881.784.852.391.85
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Everest Organics Ltd. should be analysed on a Standalone basis
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales 13.4%9.6%16.1%7.3%
Adjusted EPS 30.4%42.6%108.7%42.6%
Book Value per Share 4446.928.531.7
Share Price - 59.9% 27.6% 160.7%
Key Financial Parameter
Performance Ratio Colour Code Guide
Return on Equity (%) 34.5143.3719.2219.4542.2612.2810.618.9433.5635.53
Operating Profit Margin (%) 8.189.496.815.517.346.015.626.3111.4411.46
Net Profit Margin (%) 2.131.960.880.831.990.731.11.394.816.39
Debt to Equity 12.317.285.876.344.114.621.071.180.820.52
Working Capital Days 128142131126129147154160128139
Cash Conversion Cycle -1064-5-11-16-24-26-16-3
Entity Percentage Holding
Promoters 74.04%
Institutions 0.03%
Non-Institutions 25.94%
Pledged *
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Everest Organics Ltd's performance infers:

Everest Organics Ltd earnings have grown by 42.6%, whereas share price has appreciated 59.9% CAGR over the past five years, indicating the company's share price is likely overvalued. However, for specific investment actions please connect with your investment advisor.

Data is not available for this company

No data to display
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323